Stonehage Fleming (UK)’s Pfizer PFE Stock Holding History

Stonehage Fleming (UK)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$478K	Hold	15,599	–	–	0.22%	117
2015 Q3	$467K	Sell	15,599 -1,054	-6%	-$33.8K	0.22%	108
2015 Q2	$537K	Sell	16,653 -125,110	-88%	-$4.08M	0.24%	101
2015 Q1	$4.68M	Buy	141,763 +16,457	+13%	+$523K	2.17%	4
2014 Q4	$3.7M	Buy	125,306 +61,975	+98%	+$1.78M	1.82%	5
2014 Q3	$1.78M	Hold	63,331	–	–	0.79%	61
2014 Q2	$1.78M	Sell	63,331 -632	-1%	-$18K	0.72%	57
2014 Q1	$1.94M	Sell	63,963 -5,512	-8%	-$164K	0.82%	47
2013 Q4	$2.02M	Buy	+69,475	New	+$2.02M	0.82%	45

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Stonehage Fleming (UK)'s PFE Position: Q4 2015 in Review

Stonehage Fleming (UK) held its Pfizer (PFE) position steady in Q4 2015 at 15,599 shares worth $478K. The position accounts for 0.22% of the portfolio, ranked #117.

Stonehage Fleming (UK) first reported a position in PFE in Q4 2013 and has held it in 9 quarters since. The position peaked at $4.68M in Q1 2015. 1,970 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

Stonehage Fleming (UK) held 15,599 shares of Pfizer worth $478K as of Q4 2015.
Stonehage Fleming (UK) left its Pfizer share count unchanged in Q4 2015.
Pfizer made up 0.22% of Stonehage Fleming (UK)'s portfolio in Q4 2015, its #117 holding.
Stonehage Fleming (UK) first reported a position in Pfizer in Q4 2013 and has held it in 9 quarters since.
Stonehage Fleming (UK)'s Pfizer position peaked at $4.68M in Q1 2015.
1,970 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q4 2015, filed 11 Oct 2019.